Alvine Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing therapeutics for autoimmune/gastrointestinal diseases. Alvine's lead product candidate, ALV003, is a combination protease engineered to digest gluten. It is being developed to treat patients with celiac disease.
Current Team (12)Update
Chief Medical Officer, Senior Vice President, Development
Chief Business Officer, Senior Vice President
Vice President of Marketing and Corporate & Strategic Development
President and CEO
Vice President of Quality and Regulatory Affairs
Vice-President of Process and Product Development
Funding Rounds (6) - $70MUpdate
Board Members and Advisors (3)Update
75 Shoreway Rd.
San Carlos, CA 94070